Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysis (Q34352867)

From Wikidata

Jump to navigation Jump to search

scientific article published on 12 November 2013

Language	Label	Description	Also known as
English	Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysis	scientific article published on 12 November 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

0 references

Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

Hashem El-Serag

5

object named as

Hashem B El-Serag

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

author name string

Siddharth Singh

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Sushil Kumar Garg

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Preet Paul Singh

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Prasad G Iyer

4

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

language of work or name

0 references

publication date

12 November 2013

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

63

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1229-1237

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Recent developments in esophageal adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199831

6 July 2018

Statins are associated with reduced risk of esophageal cancer, particularly in patients with Barrett's esophagus: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199831

6 July 2018

The role of bile acids in the neoplastic progression of Barrett's esophagus - a short representative overview

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199831

6 July 2018

A combination of esomeprazole and aspirin reduces tissue concentrations of prostaglandin E(2) in patients with Barrett's esophagus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199831

6 July 2018

Nonsteroidal anti-inflammatory drug use reduces risk of adenocarcinomas of the esophagus and esophagogastric junction in a pooled analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199831

6 July 2018

GRADE guidelines: 7. Rating the quality of evidence--inconsistency

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199831

6 July 2018

Epidemiology and natural history of intestinal metaplasia of the gastroesophageal junction and Barrett's esophagus: a population-based study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199831

6 July 2018

American Gastroenterological Association technical review on the management of Barrett's esophagus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199831

6 July 2018

Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199831

6 July 2018

Risk of esophageal adenocarcinoma and mortality in patients with Barrett's esophagus: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199831

6 July 2018

Long-term safety concerns with proton pump inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199831

6 July 2018

Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199831

6 July 2018

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199831

6 July 2018

Medication usage and the risk of neoplasia in patients with Barrett's esophagus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199831

6 July 2018

Treatment modality and risk of development of dysplasia and adenocarcinoma in columnar-lined esophagus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199831

6 July 2018

Patient preferences for the chemoprevention of esophageal adenocarcinoma in Barrett's esophagus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199831

6 July 2018

Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199831

6 July 2018

Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199831

6 July 2018

Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199831

6 July 2018

A methodologic analysis of chemoprevention and cancer prevention strategies for gastrointestinal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199831

6 July 2018

Barrett's oesophagus and oesophageal adenocarcinoma: how does acid interfere with cell proliferation and differentiation?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199831

6 July 2018

Gastrin-induced cyclooxygenase-2 expression in Barrett's carcinogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199831

6 July 2018

Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199831

6 July 2018

Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199831

6 July 2018

Review article: Barrett's oesophagus, dysplasia and pharmacologic acid suppression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199831

6 July 2018

Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199831

6 July 2018

Meta-analysis in clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199831

6 July 2018

Chemoprevention and Barrett's esophagus: decisions, decisions

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305997

21 January 2018

Proton Pump Inhibitors Reduce the Risk of Neoplastic Progression in Patients With Barrett's Esophagus

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305997

21 January 2018

Risk Factors for the Development of Esophageal Adenocarcinoma in Barrett's Esophagus

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305997

21 January 2018

Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305997

21 January 2018

Predictors for neoplastic progression in patients with Barrett's Esophagus: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305997

21 January 2018

Risk factors for progression of low-grade dysplasia in patients with Barrett's esophagus.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305997

21 January 2018

Use of Proton Pump Inhibitors and Risk of Progression of Barrett's Esophagus to Neoplastic Lesions

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305997

21 January 2018

Gastrin induces proliferation in Barrett's metaplasia through activation of the CCK2 receptor

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305997

21 January 2018

Long-term proton pump induced hypergastrinaemia does induce lineage-specific restitution but not clonal expansion in benign Barrett's oesophagus in vivo.

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305997

21 January 2018

Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression

1 reference

https://pubmed.ncbi.nlm.nih.gov/24221456

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Barrett's oesophagus, proton pump inhibitors and gastrin: the fog is clearing

1 reference

https://pubmed.ncbi.nlm.nih.gov/24221456

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

"Systematic Reviews and Meta-analyses" in Clinical Gastroenterology and Hepatology

1 reference

https://pubmed.ncbi.nlm.nih.gov/24221456

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/GUTJNL-2013-305997

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

release_rar7z3onjfaihmjrhia5r5hati

1 reference

https://api.fatcat.wiki/v0/release/rar7z3onjfaihmjrhia5r5hati

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34352867&oldid=2042175611"